Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Targeting Hypertension Screening in Low-And Middle-Income Countries: A Cross-Sectional Analysis of 1.2 Million Adults in 56 Countries Publisher Pubmed



Kirschbaum TK1 ; Theilmann M1 ; Sudharsanan N1 ; Mannegoehler J2 ; Lemp JM1 ; De Neve JW1 ; Marcus ME3 ; Ebert C4 ; Chen S1, 5 ; Aryal KK6 ; Bahendeka SK7 ; Norov B8 ; Damasceno A9 ; Dorobantu M10 Show All Authors
Authors
  1. Kirschbaum TK1
  2. Theilmann M1
  3. Sudharsanan N1
  4. Mannegoehler J2
  5. Lemp JM1
  6. De Neve JW1
  7. Marcus ME3
  8. Ebert C4
  9. Chen S1, 5
  10. Aryal KK6
  11. Bahendeka SK7
  12. Norov B8
  13. Damasceno A9
  14. Dorobantu M10
  15. Farzadfar F11
  16. Fattahi N11
  17. Gurung MS12
  18. Guwatudde D13
  19. Labadarios D14
  20. Lunet N15
  21. Rayzan E11
  22. Moghaddam SS16
  23. Webster J17
  24. Davies JI18, 19, 20
  25. Atun R21
  26. Vollmer S3
  27. Barnighausen T1, 5
  28. Jaacks LM21, 22, 23
  29. Geldsetzer P1, 24
Show Affiliations
Authors Affiliations
  1. 1. Heidelberg Institute of Global Health, Medical Faculty and University Hospital, University of Heidelberg, Germany
  2. 2. Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
  3. 3. Department of Economics and Centre for Modern Indian Studies, University of Goettingen, Germany
  4. 4. RWI-Leibniz Institute for Economic Research, Berlin, Germany
  5. 5. Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
  6. 6. Monitoring Evaluation and Operational Research Project, Abt Associates, Kathmandu, Nepal
  7. 7. Saint Francis Hospital, Nsambya, Kampala, Uganda
  8. 8. National Center for Public Health, Ulaanbaatar, Mongolia
  9. 9. Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique
  10. 10. Cardiology Department, Emergency Hospital of Bucharest, Romania
  11. 11. Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  12. 12. Health Research and Epidemiology Unit, Policy and Planning Division, Ministry of Health, Thimphu, Bhutan
  13. 13. Department of Epidemiology and Biostatistics, School of Public Health, Makerere University, Kampala, Uganda
  14. 14. Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa
  15. 15. Departamento de Ciencias da Saude Publica e Forenses e Educacao Medica, Faculdade de Medicina da Universidade do Porto, Porto, Portugal
  16. 16. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  17. 17. The George Institute for Global Health, University of New South Wales, Sydney, Australia
  18. 18. Institute of Applied Health Research, University of Birmingham, United Kingdom
  19. 19. Centre for Global Surgery, Department of Global Health, Stellenbosch University, Cape Town, South Africa
  20. 20. Medical Research Council/Wits University Rural Public Health and Health Transitions Research Unit, Faculty of Health Sciences, School of Public Health University of the Witwatersrand, Johannesburg, South Africa
  21. 21. Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, United States
  22. 22. Public Health Foundation of India, New Delhi, India
  23. 23. Global Academy of Agriculture and Food Security, The University of Edinburgh, Midlothian, United Kingdom
  24. 24. Division of Primary Care and Population Health, Department of Medicine, Stanford University, Stanford, CA, United States

Source: Journal of the American Heart Association Published:2021


Abstract

BACKGROUND: As screening programs in low-and middle-income countries (LMICs) often do not have the resources to screen the entire population, there is frequently a need to target such efforts to easily identifiable priority groups. This study aimed to determine (1) how hypertension prevalence in LMICs varies by age, sex, body mass index, and smoking status, and (2) the ability of different combinations of these variables to accurately predict hypertension. METHODS AND RESULTS: We analyzed individual-level, nationally representative data from 1 170 629 participants in 56 LMICs, of whom 220 636 (18.8%) had hypertension. Hypertension was defined as systolic blood pressure ≥140 mm Hg, diastolic blood pressure≥90 mm Hg, or reporting to be taking blood pressure-lowering medication. The shape of the positive association of hypertension with age and body mass index varied across world regions. We used logistic regresson and random forest models to compute the area under the receiver operating characteristic curve in each country for different combinations of age, body mass index, sex, and smoking status. The area under the receiver operating characteristic curve for the model with all 4 predictors ranged from 0.64 to 0.85 between countries, with a country-level mean of 0.76 across LMICs globally. The mean absolute increase in the area under the receiver operating characteristic curve from the model including only age to the model including all 4 predictors was 0.05. CONCLUSIONS: Adding body mass index, sex, and smoking status to age led to only a minor increase in the ability to distinguish between adults with and without hypertension compared with using age alone. Hypertension screening programs in LMICs could use age as the primary variable to target their efforts. © 2021 The Authors.
Experts (# of related papers)
Other Related Docs
14. Direct Costs of Hypertension Treatment in Iran, Iranian Journal of Public Health (2023)
35. Effect of Vitamin D3 Supplementation on Blood Pressure in Adults: An Updated Meta-Analysis, Nutrition# Metabolism and Cardiovascular Diseases (2016)